PT  - JOURNAL ARTICLE
AU  - Smith, Brianna A.
AU  - Ricotta, Emily E.
AU  - Kwan, Jennifer L.
AU  - Evans, Nicholas G.
TI  - COVID-19 risk perception and vaccine acceptance in individuals with chronic disease
AID  - 10.1101/2021.03.17.21253760
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2021.03.17.21253760
4099  - http://medrxiv.org/content/early/2022/08/16/2021.03.17.21253760.short
4100  - http://medrxiv.org/content/early/2022/08/16/2021.03.17.21253760.full
AB  - Background COVID-19 disproportionately affects those with preexisting conditions, but little research has determined whether those with chronic diseases view the pandemic itself differently - and whether there are differences between chronic diseases. We theorized that while individuals with respiratory disease or autoimmune disorders would perceive greater threat from COVID-19 and be more supportive of non-pharmaceutical interventions (NPIs), those with autoimmune disorders would be less likely to support vaccination-based interventions.Methods We conducted a two-wave online survey conducted in February and November 2021 asking respondents their beliefs about COVID-19 risk perception, adoption and support of interventions, willingness to be vaccinated against COVID-19, and reasons for vaccination. Regression analysis was conducted to assess the relationship of respondents reporting a chronic disease and COVID-19 behaviors and attitudes, compared to healthy respondents adjusting for demographic and political factors.Results In the initial survey, individuals reporting a chronic disease had stronger both stronger feelings of risk from COVID-19 as well as preferences for NPIs than healthy controls. The only NPI that was still practiced significantly more compared to healthy controls in the resample was limiting trips outside of the home. Support for community-level NPIs was higher among individuals reporting a chronic disease than healthy controls and remained high among those with respiratory diseases in sample 2. Vaccine acceptance produced more divergent results: those reporting chronic respiratory diseases were 6% more willing to be vaccinated than healthy controls, while we found no significant difference between individuals with autoimmune diseases and healthy controls. Respondents with chronic respiratory disease and those with autoimmune diseases were more likely to want to be vaccinated to protect themselves from COVID-19, and those with an autoimmune disease were more likely to report fear of a bad vaccine reaction as the reason for vaccine hesitancy. In the resample, neither those with respiratory diseases nor autoimmune diseases reported being more willing to receive a booster vaccine than healthy controls.Conclusions It is not enough to recognize the importance of health in determining attitudes: nuanced differences between conditions must also be recognized.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNGE was supported by The Greenwall Foundation Faculty Scholars Program, the National Science Foundation (#1734521) and the US Air Force Office of Scientific Research (FA9550-21-1-0142). BAS was supported by the US Naval Academy. JLK and EER were supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The United States Naval Academy IRB approved this research.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll deidentified data is archived by the authors and is available on requestACSAmerican Community SurveyCIConfidence IntervalNPINonpharmaceutical interventionOLSOrdinary least squares